Join Corning to learn about new vial parenteral packaging technology that increases drug product quality by addressing the root cause of issues associated with conventional glass containers. Allison Matusick, Corning Global Account Director and subject matter expert, will share how this new packaging is capable of reducing glass damage and breakage in extreme applications, reducing particulate generation, eliminating delamination, improving manufacturing efficiency for sterile injectable drugs and improving quality to enhance patient safety. Adoption of this next generation glass may positively impact regulations, improve bio manufacturing throughput, and could potentially alleviate quality control practices for bio manufacturing operations relevant to costly container crack failures.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):